Pneumonia

Pneumonia is an infection of the lung parenchyma — the alveoli, the tiny air sacs where oxygen crosses into the blood — that fills those spaces with inflammatory fluid, pus, and cellular debris. When the alveoli flood, gas exchange fails, and a patient who was walking around yesterday can be gasping for breath today. For most of human history this was one of the leading causes of death at every age, and it remains a top killer worldwide, especially in children under five and adults over sixty-five.

What makes pneumonia such a rewarding topic to master is that it sits at the crossroads of microbiology, physiology, imaging, and pharmacology. Get the reasoning right — where did the patient acquire it, which organism is likely, how sick are they, which antibiotic — and you can turn a life-threatening illness into a routine outpatient course. This page teaches that reasoning the way a good clinician actually thinks.

Learning Objectives

• Define pneumonia and distinguish it from bronchitis and other lower respiratory infections.
• Classify pneumonia by where it was acquired (community-acquired, hospital-acquired, ventilator-associated) and explain why this drives treatment.
• List the typical and atypical pathogens for each setting and the patient factors that shift the likely organism.
• Describe the diagnostic workup: history, examination signs, chest radiography, and laboratory tests.
• Apply the CURB-65 severity score to decide the site of care.
• Outline rational empirical antibiotic therapy and the principles of de-escalation.
• Recognise complications, common clinical mistakes, and prevention through vaccination.

Quick Answer

Pneumonia is an acute infection of the lung tissue causing cough, fever, breathlessness, and characteristic findings on examination and chest X-ray (consolidation). It is classified by setting: community-acquired pneumonia (CAP) develops outside hospital and is most often caused by Streptococcus pneumoniae, while hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) arise 48 hours or more after admission and involve more resistant Gram-negative bacteria and Staphylococcus aureus. Diagnosis combines clinical features with a chest radiograph showing new infiltrates. Severity is graded (for CAP, the CURB-65 score) to decide home versus ward versus intensive care. Treatment is prompt empirical antibiotics chosen for the likely pathogens and local resistance, later narrowed once cultures return. Vaccination and good ward hygiene prevent a large share of cases.

Where It Came From

Pneumonia has stalked humanity since antiquity — Hippocrates described the fever, cough, and rusty sputum of "peripneumonia" around 400 BCE. For over two thousand years there was nothing to offer but bed rest, poultices, and prayer. The disease killed so reliably, and so often ended the lives of the elderly and the chronically ill, that the great Canadian physician Sir William Osler famously called it "the captain of the men of death" in his 1892 textbook — deliberately borrowing a phrase John Bunyan had earlier applied to tuberculosis. Osler noted, with clinical resignation, that pneumonia was often "the friend of the aged," carrying off the infirm quickly and with comparatively little suffering. That fatalism reflected medical reality: in the pre-antibiotic era, roughly one in three hospitalised pneumonia patients died.

The scientific turning point came in the late nineteenth century. In 1881 both Louis Pasteur in France and George Sternberg in the United States independently isolated the pneumococcus from human saliva. By the 1920s and 1930s, serotyping of Streptococcus pneumoniae allowed the first serum therapies, which lowered mortality modestly. But the true revolution was chemotherapy. Sulphonamides arrived in the mid-1930s and cut pneumococcal deaths sharply. Then came penicillin — discovered by Alexander Fleming in 1928 and turned into a usable drug by Howard Florey and Ernst Chain during the Second World War. Penicillin was almost miraculously effective against the pneumococcus, and by the late 1940s the captain of the men of death had been, for the first time, decisively challenged.

The need that drove all this was simple and enormous: a common, fast-moving, universally fatal infection with no cure. Every subsequent chapter — new antibiotics, resistance, vaccines, the recognition of atypical organisms and hospital superbugs — is a response to the moving target that pneumonia became once we started fighting back.

Classifying Pneumonia: Where You Caught It Matters Most

The single most useful question in pneumonia is not "which bug?" but "where did the patient acquire the infection?" Setting predicts the likely organisms and their resistance, and therefore the right empirical antibiotic before any culture returns.

Community-acquired pneumonia (CAP) develops in a person living in the community, or within the first 48 hours of a hospital stay. The organisms are the "ordinary" respiratory pathogens the person carried or inhaled from daily life.

Hospital-acquired pneumonia (HAP), also called nosocomial pneumonia, is defined as pneumonia arising 48 hours or more after admission, not incubating at the time of arrival. Hospitalised patients are colonised within days by the tougher flora of the ward — Gram-negative rods and resistant staphylococci — and are often debilitated, sedated, or unable to clear secretions.

Ventilator-associated pneumonia (VAP) is HAP developing more than 48 hours after endotracheal intubation. The tube bypasses the natural airway defences and provides a highway for organisms to reach the lungs; VAP is one of the most common and dangerous infections in intensive care.

An older term, "healthcare-associated pneumonia" (HCAP), was used for patients from nursing homes or on dialysis, but recent guidelines have largely abandoned it because it over-prescribed broad antibiotics; risk is now assessed patient by patient.

Two anatomical patterns are worth knowing. Lobar pneumonia consolidates a whole lobe in a uniform sheet, the classic pneumococcal picture. Bronchopneumonia is patchy, centred on the airways, and scattered through both lungs — typical of staphylococci and hospital organisms. A third pattern, interstitial pneumonia, spares the alveoli somewhat and inflames the tissue between them, characteristic of viruses and atypical bacteria.

The Pathogens: Typical, Atypical, and Nosocomial

Knowing the usual suspects for each setting is what lets you choose an antibiotic that works.

For community-acquired pneumonia, the dominant pathogen everywhere is Streptococcus pneumoniae (the pneumococcus), producing abrupt fever, rigors, pleuritic chest pain, and rust-coloured sputum. Alongside it sit the atypical organisms — so named because they cause a milder, more gradual illness with prominent dry cough and systemic symptoms, and because they lack a conventional cell wall or live inside cells, so they do not respond to penicillins. The key atypicals are Mycoplasma pneumoniae (young adults, "walking pneumonia," sometimes with extrapulmonary features), Chlamydophila pneumoniae, and Legionella pneumophila (linked to contaminated water systems, causing severe pneumonia with confusion, diarrhoea, and low sodium). Haemophilus influenzae matters in smokers and those with COPD. Respiratory viruses — influenza, and more recently SARS-CoV-2 — cause pneumonia directly and predispose to bacterial superinfection, classically Staphylococcus aureus after influenza.

For hospital-acquired and ventilator-associated pneumonia, the flora shifts toward resistant Gram-negatives — Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Acinetobacter — and Staphylococcus aureus, including MRSA (methicillin-resistant S. aureus). These organisms are hardier and often multidrug-resistant, which is exactly why HAP demands broader initial cover than CAP.

Certain hosts point to certain bugs. Alcohol use disorder raises the risk of Klebsiella (classic "currant-jelly" sputum) and aspiration; immunocompromise (HIV, chemotherapy) opens the door to Pneumocystis jirovecii and fungi; recent influenza points to staphylococcal superinfection; and impaired swallowing or reduced consciousness leads to aspiration pneumonia, involving mouth anaerobes and affecting dependent lung segments.

Making the Diagnosis

Diagnosis rests on three legs: history and examination, imaging, and targeted laboratory tests.

History typically reveals cough (productive or dry), fever, breathlessness, and pleuritic chest pain, often over a few days. In older adults the presentation can be deceptively quiet — confusion, a fall, or simply "off legs" may be the only clue, with fever absent.

Examination of the affected zone shows the signs of consolidation: reduced chest expansion, dull percussion note, increased vocal resonance and tactile fremitus, bronchial breath sounds, and inspiratory crackles. Tachypnoea (a fast respiratory rate) is one of the most sensitive early signs and is frequently overlooked. Check the oxygen saturation and respiratory rate in every suspected case.

Chest radiography is the standard confirmation: a new infiltrate or area of consolidation establishes the diagnosis and shows its extent, whether one lobe or several, and whether there is a pleural effusion. Note that the X-ray can lag behind the clinical picture and may be normal very early or in dehydrated patients.

Laboratory tests support and refine. A full blood count often shows a raised neutrophil count; C-reactive protein and procalcitonin help gauge severity and bacterial likelihood. For patients sick enough to admit, obtain blood cultures and sputum for Gram stain and culture before antibiotics, plus urinary antigen tests for pneumococcus and Legionella, and respiratory viral PCR (including influenza and SARS-CoV-2) where relevant. Arterial blood gas or pulse oximetry assesses gas exchange.

Worked example — scoring severity with CURB-65

CURB-65 grades CAP severity and guides where to treat. Award one point each for:

• Confusion (new disorientation)
• Urea greater than 7 mmol/L
• Respiratory rate 30 breaths/min or higher
• Blood pressure low (systolic under 90, or diastolic 60 or under)
• Age 65 or older

Consider a 72-year-old man with a cough, respiratory rate of 32, blood pressure 105/70, urea 9 mmol/L, and clear thinking. Score: age (1) + respiratory rate (1) + urea (1) = 3. A score of 0–1 usually means safe home treatment; 2 suggests a short admission or close observation; 3 or more indicates severe pneumonia warranting hospital admission and consideration of intensive care. This patient should be admitted. The score never replaces clinical judgement — a young patient with a score of 0 but an oxygen saturation of 88% still needs admission.

Treatment: Prompt, Empirical, Then Focused

The governing principle is start effective antibiotics early — delay costs lives, especially in severe disease — using an empirical choice matched to the setting and severity, then de-escalate to a narrow agent once the organism and its sensitivities are known.

For mild CAP managed at home, a single oral agent is usually enough: amoxicillin is first-line in many guidelines, with a macrolide (such as clarithromycin) or doxycycline as an alternative or when an atypical organism is suspected. For moderate to severe CAP, combination therapy covers both typical and atypical pathogens — for example a beta-lactam (co-amoxiclav or a third-generation cephalosporin such as ceftriaxone) plus a macrolide, or a respiratory fluoroquinolone (levofloxacin) alone. Add oxygen to keep saturations in target range, fluids, and analgesia for pleuritic pain.

For HAP and VAP, empirical cover must be broader because resistant Gram-negatives and MRSA are in play. Regimens typically include an antipseudomonal beta-lactam (piperacillin-tazobactam, or an antipseudomonal cephalosporin/carbapenem) and, where MRSA is a risk, vancomycin or linezolid — always guided by local antibiogram data, because resistance patterns vary from one hospital to the next.

Duration has shortened over the years: most CAP now needs only 5 days if the patient is improving and afebrile, and many HAP courses run 7 days. Review at 48–72 hours, switch from intravenous to oral once the patient is stable ("IV-to-oral switch"), and stop early rather than treating "just in case." Supportive care — oxygen, hydration, chest physiotherapy, and mobilisation — matters as much as the drug.

Real-World Applications

In everyday general practice, distinguishing pneumonia from acute bronchitis (which does not need antibiotics) prevents both dangerous undertreatment and needless antibiotic use that fuels resistance. In emergency medicine, the CURB-65 score and oxygen saturation triage patients quickly and safely to home, ward, or ICU. In intensive care, VAP-prevention "bundles" — elevating the head of the bed, daily sedation holds and readiness-to-wean assessments, oral care with chlorhexidine, and subglottic secretion drainage — measurably cut infection rates and are a benchmark of ward quality. In public health, pneumococcal and influenza vaccination of children and older adults has driven large falls in pneumonia deaths, and every clinical encounter is a chance to check a patient's vaccination status.

Common Mistakes

• Treating every cough and fever as pneumonia (or bronchitis as pneumonia). Acute bronchitis is usually viral, self-limiting, and has a normal chest X-ray. Prescribing antibiotics for it does not help and drives resistance. The correction: confirm consolidation clinically and, when in doubt, radiologically before committing to a bacterial diagnosis.
• Giving a penicillin alone for suspected atypical pneumonia. Atypicals like Mycoplasma and Legionella lack the cell-wall target penicillins attack, so they simply do not respond. The correction: cover atypicals with a macrolide, doxycycline, or a respiratory fluoroquinolone when the picture or severity warrants it.
• Applying CAP antibiotics to a patient who developed pneumonia in hospital. A patient becoming ill on day five of an admission likely harbours resistant Gram-negatives or MRSA that narrow CAP regimens miss. The correction: classify by timing (48-hour rule) and broaden empirical cover for HAP/VAP guided by local resistance data.
• Missing pneumonia in the elderly because there is no fever. Older patients may present only with confusion, falls, or functional decline. The correction: check respiratory rate and oxygen saturation, and keep pneumonia high on the list even without classic symptoms.

Comparison and Connections

Pneumonia is easily confused with other lower respiratory conditions. The table below highlights the distinctions that change management.

Feature	Community-acquired (CAP)	Hospital-acquired (HAP/VAP)	Acute bronchitis
Where acquired	In the community	48 h or more after admission	Community
Main pathogens	Pneumococcus, atypicals, viruses	Resistant Gram-negatives, MRSA	Viruses mostly
Chest X-ray	New consolidation	New infiltrate	Normal
First-line therapy	Amoxicillin, or beta-lactam plus macrolide	Broad, antipseudomonal, guided by antibiogram	Usually none
Typical severity	Variable	Often severe	Mild

It is also worth connecting pneumonia to sepsis (severe pneumonia is a leading cause), to tuberculosis (a slower, chronic pneumonia with weight loss and haemoptysis — always considered when illness is subacute), and to pleural effusion and empyema, which are pneumonia's most common local complications and may need drainage.

Practice Questions

Recall

Q: What defines hospital-acquired pneumonia, and why does the definition matter? A: Pneumonia developing 48 hours or more after hospital admission (and not incubating on arrival). It matters because these patients are colonised with resistant hospital flora — Gram-negatives and MRSA — so empirical antibiotics must be broader than for CAP.

Understanding

Q: Why do penicillins fail against atypical pneumonia pathogens? A: Penicillins work by disrupting bacterial cell-wall synthesis. Atypicals such as Mycoplasma lack a conventional cell wall (and Legionella/Chlamydophila are largely intracellular), so the drug has no effective target. Macrolides, tetracyclines, and fluoroquinolones, which act on protein synthesis or DNA, are needed instead.

Application

Q: A 68-year-old woman has CAP with respiratory rate 28, blood pressure 118/76, urea 6 mmol/L, and normal cognition. Calculate her CURB-65 and decide disposition. A: Points: age 65+ (1); respiratory rate is under 30 (0); blood pressure normal (0); urea under 7 (0); no confusion (0). CURB-65 = 1, suggesting she can often be managed at home with oral antibiotics — provided oxygen saturation and social circumstances are adequate.

Analysis

Q: An ICU patient intubated for six days develops fever, purulent secretions, a new infiltrate, and worsening oxygenation. How should empirical treatment differ from a young adult with mild CAP, and why? A: This is VAP. Unlike mild CAP (treatable with a single narrow oral agent for pneumococcus/atypicals), VAP requires broad intravenous cover for resistant Gram-negatives including Pseudomonas, plus MRSA cover such as vancomycin or linezolid where local rates warrant it, all guided by the unit's antibiogram — because the causative organisms are hospital-acquired and frequently multidrug-resistant. Cultures should be sent and therapy de-escalated once sensitivities return.

FAQ

Is pneumonia contagious? The organisms that cause it — pneumococcus, Mycoplasma, influenza, SARS-CoV-2 — spread person to person by respiratory droplets. But "catching" the organism is not the same as developing pneumonia; whether infection reaches the lungs depends on host defences, age, and comorbidity. Aspiration and hospital-acquired pneumonias are not typically person-to-person contagious.

What is "walking pneumonia"? A colloquial term for mild pneumonia, usually caused by Mycoplasma pneumoniae, where the person feels unwell with a dry cough and low-grade fever but is well enough to keep going about daily life. It still deserves appropriate antibiotics if bacterial.

How long does recovery take? Fever often settles within a few days of effective antibiotics, but full recovery is slower: fatigue and cough can linger for weeks, and the chest X-ray may take 6 weeks or more to clear. Older or sicker patients recover more slowly. A cough that fails to resolve, or persistent radiographic shadowing, warrants follow-up to exclude underlying lung cancer or tuberculosis.

Do I always need a chest X-ray? Not for mild suspected CAP managed in primary care, where treatment can be started on clinical grounds. An X-ray is important when the diagnosis is uncertain, the patient is being admitted, or they are not improving, to confirm consolidation and detect complications like effusion.

Can pneumonia be prevented? Substantially, yes. Pneumococcal and annual influenza vaccination cut both incidence and severity, particularly in the very young, the elderly, and those with chronic disease. Not smoking, good nutrition, and, in hospital, VAP-prevention bundles and hand hygiene all reduce risk.

Quick Revision

• Pneumonia = infection of the lung parenchyma; alveoli fill with fluid/pus, impairing gas exchange.
• Classify by setting: CAP (community); HAP (48 h+ after admission); VAP (48 h+ after intubation).
• CAP top pathogen: Streptococcus pneumoniae; atypicals (Mycoplasma, Legionella) need macrolides/doxycycline, not penicillin.
• HAP/VAP: resistant Gram-negatives (Pseudomonas, Klebsiella) and MRSA — broad empirical cover guided by local antibiogram.
• Diagnose with clinical signs of consolidation plus a new infiltrate on chest X-ray; send cultures and urinary antigens if admitting.
• CURB-65 (Confusion, Urea >7, RR ≥30, low BP, age ≥65) grades CAP severity and site of care; 3+ is severe.
• Treat early and empirically, then de-escalate; 5-day courses suffice for most improving CAP.
• Osler's "captain of the men of death" was tamed by sulphonamides and penicillin in the 1930s–40s.
• Prevent with pneumococcal and influenza vaccination and, in hospital, VAP-prevention bundles.

Related Topics

Prerequisites

• Pulmonology overview
• Respiratory physiology and gas exchange — see Physiology

Related Topics

• Antibiotics and antimicrobial resistance — see Pharmacology
• Respiratory pathogens — see Microbiology
• Sepsis and severe infection — see Critical Care Medicine

Next Topics

• Tuberculosis (chronic infective lung disease) — see Infectious Diseases
• Pleural effusion and empyema (complications of pneumonia)